Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video game meets glucose monitor: a new way to teach diabetes skills to children

NCT ID NCT07726680

Disease control Sponsor: Shifa International Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether GlycoQuest, a video game that connects to a continuous glucose monitor and adapts using artificial intelligence, can help children aged 6 to 17 who were diagnosed with type 1 diabetes in the past three months. The game includes a glucose-responsive avatar, decision simulations, and parent-child missions to teach diabetes management and reduce emotional distress. Half of the 110 parent-child pairs will use GlycoQuest plus standard care, while the other half receives enhanced digital education. The study measures changes in blood sugar time-in-range and diabetes distress after eight months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an AI-adaptive serious game digital therapeutic called GlycoQuest that integrates with continuous glucose monitoring
What this could lead to
If it works, GlycoQuest could offer a fun, personalized way for children and families to learn diabetes management skills while improving blood sugar control and emotional well-being.
What could go wrong
This is a relatively small, early-stage trial. The game may not improve outcomes more than standard education, and its effectiveness could depend heavily on how engaged families stay over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Child or adolescent aged 6 to 17 years at enrollment. * Diagnosis of type 1 diabetes confirmed by a pediatric endocrinologist according to standard clinical criteria. * Type 1 diabetes diagnosed within the previous 3 months. * Primary caregiver aged 18 years or older willing to participate as part of a parent-child dyad. * Current use of continuous glucose monitoring or willingness to initiate CGM as part of standard diabetes care. * Household access to a compatible smartphone or tablet, or willingness to use a study-provided device if available. * Ability of child and caregiver to engage with study procedures and digital intervention content. * Caregiver able to provide written informed consent. * Child able to provide age-appropriate assent. Exclusion Criteria: * Type 1 diabetes diagnosed more than 3 months before enrollment. * Concurrent participation in another intensive diabetes behavioral intervention trial. * Significant developmental, intellectual, visual, motor, or psychiatric condition that, in the opinion of the clinical team, would preclude meaningful engagement with the digital game interface or study procedures. * Acute psychiatric instability or safety concern requiring urgent specialist intervention. * Planned transfer to a different diabetes care provider within 6 months. * Absence of internet access that cannot be addressed by study support.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes distress are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypoglycemia type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes distress Family conflict Hypoglycemia (diabetic) Type 1 diabetes mellitus (T1DM)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shifa International hospital

    RECRUITING

    Lahore, Punjab Province, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.